BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghaye B, Wanet M, El Hajjam M. Imaging after radiation therapy of thoracic tumors. Diagn Interv Imaging 2016;97:1037-52. [PMID: 27567554 DOI: 10.1016/j.diii.2016.06.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Zeng B, Xue D, Cao R, Liao S, Yang Y, Li Z, Kang M, Chen C, Xu B. Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial. BMJ Open 2022;12:e060619. [PMID: 36302570 DOI: 10.1136/bmjopen-2021-060619] [Reference Citation Analysis]
2 Hao Y, Zhang X, Yu L. Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review. Front Oncol 2022;12:911906. [DOI: 10.3389/fonc.2022.911906] [Reference Citation Analysis]
3 Deng X, Milligan K, Ali-Adeeb R, Shreeves P, Brolo A, Lum JJ, Andrews JL, Jirasek A. Group and Basis Restricted Non-Negative Matrix Factorization and Random Forest for Molecular Histotype Classification and Raman Biomarker Monitoring in Breast Cancer. Appl Spectrosc 2021;:37028211035398. [PMID: 34355582 DOI: 10.1177/00037028211035398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pirasteh A, Lovrec P, Pedrosa I. Imaging and its Impact on Defining the Oligometastatic State. Semin Radiat Oncol 2021;31:186-99. [PMID: 34090645 DOI: 10.1016/j.semradonc.2021.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med 2021;21:9. [PMID: 33407290 DOI: 10.1186/s12890-020-01376-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 46.0] [Reference Citation Analysis]
6 Gebauer B, Denecke T, Savic LJ, Hering AH, Schierle K, Jentzsch M, Hacker U. Remissionsparameter. Springer Reference Medizin 2021. [DOI: 10.1007/978-3-662-46764-0_1-1] [Reference Citation Analysis]
7 Ivanova L, Boltenkova V, Ivanova E, Evseev E. Risk factors of postpericardiotomy syndrome after heart valve surgery. Kardiol serdechno-sosud khir 2021;14:308. [DOI: 10.17116/kardio202114041308] [Reference Citation Analysis]
8 Faivre-Finn C, Spigel DR, Senan S, Langer C, Perez BA, Özgüroğlu M, Daniel D, Villegas A, Vicente D, Hui R, Murakami S, Paz-Ares L, Broadhurst H, Wadsworth C, Dennis PA, Antonia SJ. Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). Lung Cancer 2021;151:30-8. [PMID: 33285469 DOI: 10.1016/j.lungcan.2020.11.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
9 Cho H, Lewis AL, Storey KM. Bayesian Information-Theoretic Calibration of Radiotherapy Sensitivity Parameters for Informing Effective Scanning Protocols in Cancer. JCM 2020;9:3208. [DOI: 10.3390/jcm9103208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zeng Q, Tang C, Deng L, Li S, Liu J, Wang S, Shan H. Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy.Int J Med Sci. 2020;17:2561-2569. [PMID: 33029098 DOI: 10.7150/ijms.46133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Horinouchi H, Atagi S, Oizumi S, Ohashi K, Kato T, Kozuki T, Seike M, Sone T, Sobue T, Tokito T, Harada H, Maeda T, Mio T, Shirosaka I, Hattori K, Shin E, Murakami H. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study. Cancer Med 2020;9:6597-608. [PMID: 32730697 DOI: 10.1002/cam4.3306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
12 Chassagnon G, Martini K, Giraud P, Revel MP. Radiological assessment after stereotactic body radiation of lung tumours. Cancer Radiother 2020;24:379-87. [PMID: 32534799 DOI: 10.1016/j.canrad.2020.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zhao L, Chen S, Lin L, Sun L, Wu H, Lin Q, Chen H. [68Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer. Eur J Nucl Med Mol Imaging 2020;47:3188-9. [DOI: 10.1007/s00259-020-04818-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
14 Deng X, Ali-adeeb R, Andrews JL, Shreeves P, Lum JJ, Brolo A, Jirasek A. Monitor Ionizing Radiation-Induced Cellular Responses with Raman Spectroscopy, Non-Negative Matrix Factorization, and Non-Negative Least Squares. Appl Spectrosc 2020;74:701-11. [DOI: 10.1177/0003702820906221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sun B, Kamel MK, Nasar A, Harrison S, Lee B, Port JL, Altorki NK, Stiles BM. Staple Line Thickening After Sublobar Resection: Reaction or Recurrence? Ann Thorac Surg 2020;109:1670-6. [PMID: 32057814 DOI: 10.1016/j.athoracsur.2019.12.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Morbelli S, Calcagni ML, Cistaro A, Farsad M, Guerra L, Nanni C, Bianchi A. The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC). Clin Transl Imaging 2020;8:29-38. [DOI: 10.1007/s40336-019-00354-z] [Reference Citation Analysis]
17 Larici AR, Farchione A, Cicchetti G, del Ciello A, Mantini G, Calapaquí Terán AK, Delgado Bolton RC. Response Assessment and Follow-Up by Imaging in Lung Tumours. Imaging and Interventional Radiology for Radiation Oncology 2020. [DOI: 10.1007/978-3-030-38261-2_23] [Reference Citation Analysis]
18 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Elcim Y, Gundem E, Dirican B, Beyzadeoglu M. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective. Curr Radiopharm 2019;12:4-10. [PMID: 30465520 DOI: 10.2174/1874471012666181120162434] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
19 deSouza NM, Liu Y, Chiti A, Oprea-lager D, Gebhart G, Van Beers BE, Herrmann K, Lecouvet FE. Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group. European Journal of Cancer 2018;91:153-63. [DOI: 10.1016/j.ejca.2017.12.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 17.0] [Reference Citation Analysis]
20 Coche E. Combatting lung cancer: Advances in imaging on all fronts. Diagn Interv Imaging 2016;97:947-8. [PMID: 27743578 DOI: 10.1016/j.diii.2016.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Coche E. Le combat contre le cancer bronchopulmonaire : avancées de l’imagerie sur tous les fronts. Journal de Radiologie Diagnostique et Interventionnelle 2016;97:367-368. [DOI: 10.1016/j.jradio.2016.09.006] [Reference Citation Analysis]